相关实验视频
Updated: Jun 6, 2025

Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
在协同,添加和对抗的方法中使用阿基尼丁
Nicoleta Anca Şuţan1, Alina Paunescu1, Carmen Topala2
1Department of Natural Sciences, National University of Science and Technology POLITEHNICA Bucharest, Pitesti University Centre, 110040 Pitesti, Romania.
阿科尼是来自阿科尼物种的强效类化合物,在治疗心血管疾病和疼痛方面表现有前途. 组合疗法和纳米粒子输送可以提高其疗效并降低毒性.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 毒理学 毒理学 毒理学
背景情况:
- 阿科尼是一种来自Aconitum物种的C19-diterpenoid化物.
- 它具有心血管和神经毒性,可用于治疗心血管疾病 (CVD) 和疼痛.
- 它的高毒性需要谨慎的治疗策略.
研究的目的:
- 综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合性综合
- 探索新型药物输送系统的潜力,例如纳米颗粒,用于阿科尼丁.
- 为潜在的临床应用巩固当前的知识.
主要方法:
- 在主要科学数据库 (Web of Science,Scopus,PubMed等) 进行系统的文献搜索. 和图书馆的资源.
- 101篇相关科学论文的手动审查和综合.
- 在体内和体外对阿科尼丁组合治疗的研究分析.
主要成果:
- 在组合疗法中,阿科尼丁表现出抗心律失常,抗炎和抗增殖活性.
- 它可以减少活性氧物种 (ROS) 的产生,改善生物分布和生物可用性.
- 纳米粒子封装显示了减轻阿科尼丁毒性的潜力.
结论:
- 组合治疗和纳米粒子输送为提高阿科尼丁治疗指数提供了有希望的途径.
- 对阿科尼丁复杂相互作用的进一步研究可能会导致显著的临床进展.
- 本综述为阿科尼丁的实际和临床应用提供了基本的理解.
更多相关视频
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
07:51High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
相关概念视频
Agonism and Antagonism: Quantification
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...